CLIENT: U.S. Agency for International Development Bureau for Global Health
PRACTICE AREA: Monitoring, Evaluation, and Learning
SUBCONTRACTOR: Dexis Consulting Group
TIME PERIOD: 2020 to 2025
The Global Health EvaLS (GHEvaLS) provides evaluation, assessment, and learning support for health-related projects and activities at USAID/Washington and USAID Missions. Projects within the USAID Bureau for Global Health’s portfolio support the U.S. Government’s goals to improve global health through preventing child and maternal deaths; controlling the HIV/AIDS epidemic; and combating infectious diseases, such as COVID-19.
Under GHEvaLS, ME&A and our subcontractor, Dexis Consulting Group, provide assessments, performance and impact evaluations, and learning and adaptive management services that are transparent, based on the best methods, and oriented towards reinforcing local ownership. This includes four types of evaluations of President’s Emergency Plan For AIDS Relief (PEPFAR) programs: process, outcome, economic, and impact. PEPFAR is a U.S. governmental initiative to address the global HIV/AIDS epidemic.
The contract also involves coordinating and collaborating, as appropriate, with USAID partners, to build synergies and improve the effectiveness and efficiency of project activities. These include the U.S. Centers for Disease Control and Prevention (CDC); the Global Fund to Fight AIDS, TB, and Malaria (GFATM); and GH cooperating agency implementing partners, such as U.S. and international nongovernmental organizations and private corporations and foundations.
ME&A manages GHEvaLS from our headquarters in Bethesda, Md.
GHEvaLS is an Indefinite Delivery Indefinite Quantity (IDIQ) with a $39 million ceiling.